Prudential Financial’s Atrium Therapeutics RNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$385K Buy
+46,526
New +$549K ﹤0.01% 2068

Other funds holding RNA

Prudential Financial's RNA Position: Q3 2026 in Review

Prudential Financial opened a new position in Atrium Therapeutics (RNA) in Q3 2026: 46,526 shares worth $385K. The stake represents ﹤0.01% of the portfolio and ranks #2068 among its holdings.

146 funds tracked by Wall St. Rank hold RNA as of Q3 2026.

  • Prudential Financial held 46,526 shares of Atrium Therapeutics worth $385K as of Q3 2026.
  • Atrium Therapeutics was a new Prudential Financial position in Q3 2026.
  • Atrium Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q3 2026, its #2068 holding.
  • 146 funds tracked by Wall St. Rank held Atrium Therapeutics as of Q3 2026.

Based on Prudential Financial's 13F filing for Q3 2026, filed 16 Nov 2026.